Answers are grounded in this paper and cite their sources.
Polysaccharide-based nanoparticles have emerged as versatile nanocarriers for breast cancer therapy, owing to their excellent biocompatibility, biodegradability, low toxicity, and structural versatility. This review summarizes recent advances in the development of polysaccharide-derived nanocarriers, with particular emphasis on their structural characteristics, fabrication strategies, drug delivery mechanisms, therapeutic applications, and translational potential in breast cancer treatment. Major polysaccharides, including chitosan, alginate, dextran, hyaluronic acid, carrageenan, starch, pectin, and pullulan, are discussed with respect to their physicochemical properties, functional modifications, and suitability as drug delivery platforms. Common fabrication approaches, including ionic gelation, polyelectrolyte complexation, nanoprecipitation, emulsion solvent evaporation, green synthesis, and layer-by-layer assembly, are compared in terms of their influence on nanoparticle characteristics, drug loading, stability, and release behavior. This review further highlights key drug delivery mechanisms, including passive targeting via the enhanced permeability and retention (EPR) effect, ligand-mediated active targeting, pH-triggered and enzyme-mediated drug release, and cellular uptake with intracellular trafficking. In addition, topic modeling and academic trend analyses are incorporated to map the evolving research landscape, identify major thematic areas, and highlight shifts in research priorities within the field. Recent therapeutic applications are also discussed, encompassing chemotherapy, gene and small interfering RNA (siRNA) delivery, combination therapy, phototherapy, immunotherapy, and theranostic nanoplatforms. Furthermore, current challenges associated with physicochemical stability, pharmacokinetic behavior, long-term safety, large-scale manufacturing, and regulatory approval are critically evaluated. Collectively, this review highlights the potential of polysaccharide-based nanoparticles as multifunctional platforms for targeted breast cancer therapy and provides perspectives on future strategies to facilitate their successful clinical translation.
No takes yet. Share an insight, caveat, or question.
Gheytasi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: